|
⚲
|
| Gemin X Pharmaceuticals Inc | |
|---|---|
| Firm | |
| Fund # | |
| CIK # | 0001407168 |
| Sale | 2009-05-29 ($20.0 M Offered, $9.3 M Sold) |
| Fund | |
| Phone | 5142818989 |
| Address | 3576 Avenue Du Parc Montreal, H2X 2H7 |
| Source | [EDGAR] |
| Fund AUM and Sold ($M) |
|---|
| Fund Details | |
|---|---|
| Director | |
| Custodian | |
| Auditor | |
| Marketer | |
| Broker | |
| Jurisdiction |
| Directors | 2011 - 2025 |
|---|---|
| Jean Viallet | |
| Peter Dolan | |
| Robert Gorman | |
| Robert McNeil | |
| Timothy Barberich | |
| Andrew Jordan | |
| D Dixon | |
| Aaron Davidson | |
| Eric Roberts | |
| Gordon Shore |
| Comparable Firms | State | AUM ($B) |
|---|---|---|
|
BL Fund IV, a series of Unpopular VC, LP
✚
|
0.0 | |
|
BL Gaingels Fund I, a series of Zachary Ginsburg Funds, LP
✚
|
0.0 | |
|
Bling Capital Fund III Opps-A LP
✚
|
0.0 | |
|
Bling Capital Fund III Opps LP
✚
|
0.0 | |
|
Blitz Adam
✚
|
0.0 | |
|
Blixt Charles A
✚
|
0.0 | |
|
Bloch Kathleen B
✚
|
0.0 | |
|
Block 216 QOF II, LLC
✚
|
0.0 | |
|
Block 58 Investment Trust
✚
|
0.0 | |
|
BL Fund III, a series of AngelList-Forefront Venture Partner
✚
|
0.0 |